How One Undetected Ebola Case Traveled Across Three Countries

The man who walked through three countries with Ebola

He was a 40-year-old Kenyan businessman living in the Democratic Republic of Congo for seven years. Over nearly six weeks in the fall of 2024, he moved through some of the most dangerous Ebola zones on the continent — and no one stopped him.

His story, reconstructed by the Africa CDC, reads like a checklist of everything that can go wrong in a regional health crisis.

He fell ill around September 15 in the province of Bas-Uélé, one of three Congolese provinces where Ebola was already circulating. He was given antibiotics and sent home. Two days later, admitted to a health centre in Bondo with fever and rash — still no Ebola test. Diagnosed with a skin infection instead.

He flew to Kisangani, a city of 1.5 million, where he lingered for over ten days seeking care. Investigators do not know which clinics treated him or what medications he received.

By October 1, he boarded a domestic flight to Beni — in North Kivu, the epicentre of the outbreak with more than 1,700 cases and over 1,000 deaths — and crossed into Uganda the same day.

Ugandan airport screening registered a normal temperature. He flew to Nairobi on October 3. A relative picked him up and drove him to Nairobi Hospital. By then he was bleeding.

He died two days later. Kenya’s first Ebola case was confirmed: the Bundibugyo species, the same strain driving the Congolese outbreak.

Nearly 70 contacts have been placed under quarantine in Nairobi. The number will rise as tracing continues in Uganda and DR Congo.

Why this matters beyond East Africa

This is not simply a story about one man slipping through borders. It is a story about the architecture of global health surveillance — and how fragile it is when tested by a fast-moving pathogen crossing porous boundaries.

More than 4,000 people have died from Ebola in DR Congo this year, making this the second most deadly known outbreak in history. The virus has been present in multiple provinces. The man was not the first infected person to move through the region. He was the first to reach Kenya.

The implications are direct and uncomfortable: if Ebola can traverse thousands of kilometres across three countries without triggering a single alert, the same route is open to other pathogens.

The hotspot for this particular lesson is the border between DR Congo and Uganda. It stretches for hundreds of kilometres through remote terrain. Uganda imposed movement restrictions after the outbreak began in May, but enforcement is sporadic. Many crossings are informal. The businessman may have passed through an official checkpoint — or he may not have. That uncertainty alone is a policy problem.

Temperature checks are not a diagnostic tool

The most conspicuous failure in this chain involves airport screening. In both Uganda and Kenya, the man passed through with a normal temperature reading. Health officials have since acknowledged what epidemiologists have long known: fever-based screening misses a significant portion of early-stage Ebola cases.

The virus has an incubation period of two to 21 days. A person can be infectious and symptomatic without a measurable fever at the moment of screening — or their fever may have been suppressed by medication taken earlier in the course of illness. Dr Wessam Mankoula, the Africa CDC emergency director, said investigators are examining whether the man’s medications masked his temperature.

This is not a new finding. After the 2014 West Africa outbreak, multiple studies demonstrated the limited sensitivity of thermal screening at points of entry. Yet temperature checks remain the default entry protocol at many airports across the region and beyond. They are easy to implement and impossible to calibrate — which makes them politically popular and epidemiologically dubious.

The WHO has repeatedly called for smarter surveillance at borders: symptom questionnaires, travel-history matching, and rapid diagnostic capacity. None of these were sufficient here.

The diagnostic void in DR Congo’s health system

The man’s early misdiagnosis in DR Congo is perhaps the most telling gap. He presented with fever and rash at a health centre in Bondo. Those are textbook early symptoms of Ebola. They are also symptoms of malaria, typhoid, Lassa fever, and dozens of other conditions endemic to the region.

Without a test, any clinician is guessing. And in Bas-Uélé and Tshopo provinces — areas with limited laboratory capacity and strained health infrastructure — the odds of a correct guess are low.

This is not unique to this case. It is structural. DR Congo’s health system has been battling this outbreak since May with insufficient personnel, equipment, and community trust. Health workers have been attacked by communities that deny Ebola exists. Patients avoid facilities out of fear. The result is a shadow epidemic: confirmed cases are the tip of an iceberg that is far larger.

The Africa CDC’s reconstruction of the man’s movements is the clearest account available, but it is also incomplete. Investigators do not know which hospitals treated him in Kisangani. They do not know precisely when or where he contracted the virus. They do not know whether he passed through an official Ugandan checkpoint. These gaps matter because they determine the scope of exposure.

Who wins, who loses, and what happens next

The immediate loser is the people the man came into contact with — the 66 identified contacts in Nairobi, the healthcare workers who treated him at Nairobi Hospital, the relatives who attended his funeral before strict isolation protocols were enforced. The potential losers are every traveller passing through East African airports and every patient walking into a clinic in eastern DR Congo.

The winner, if there is one, is the data. This case has forced a public reckoning with the limitations of current surveillance protocols. The WHO is stepping up efforts to combat stigma and encourage early reporting. Kenya has designated five facilities to handle Ebola cases and trained nearly 5,000 healthcare workers. More than 652,000 travellers have been screened since the incident.

These are real measures. But they are reactive. The question that should trouble policymakers is whether similar cases will be detected next time — or whether another asymptomatic or afebrile carrier will walk through an airport and emerge three days later in a city hospital with a lethal diagnosis.

The Africa CDC’s Dr Mankoula urged travellers to report symptoms early. The WHO warned that stigma discourages reporting. Both are correct. But the deeper problem is not individual behaviour — it is a surveillance system that relies on a single, unreliable indicator (fever) at the only point where it can be measured (the airport) in a region where people move freely across vast, unmonitored borders.

Fixing that system requires more than training and designating hospitals. It requires laboratory capacity in remote provinces, shared health data between countries in real time, and community trust that makes people want to report illness rather than hide it.

None of that exists at scale today.

This case should be the threshold, not the benchmark.